Rasio utang jangka cendhak marang ekuitas: Alterity Therapeutics Limited (ATHE)
Alterity Therapeutics (ATHE) focuses on developing therapies for neurodegenerative pathologies by utilizing molecules to control metal exchange in the brain. This chart of stock quotes demonstrates the debt-to-equity dynamics, which stands at 0.00. High barriers to entry are driven by patents and strict FDA oversight. Meanwhile, the company adheres to environmental standards regarding biohazardous waste disposal in its laboratories.
Rincian analitis perusahaan Alterity Therapeutics
- kuotasi lan prakiraan analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data liabilitas lan likuiditas perusahaan:
Total Utang marang Modal Alterity Therapeutics|ATHE - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Alterity Therapeutics|ATHE - Utang perusahaan|Utang marang nilai buku Alterity Therapeutics Ltd.|ATHE - Gedhene kewajiban jangka dawa|Utang jangka cendhak perusahaan Alterity Therapeutics|Likuiditas cepet alteritytherapeutics.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
Analisis umum perusahaan:Alterity Therapeutics Limited ATHE
This ratio measures the proportion of liabilities maturing within one year relative to equity, allowing for an assessment of liquidity risk and interest rate sensitivity. For Alterity Therapeutics (ATHE), which invests in combating neurodegeneration in Parkinson's disease, the trend of short-term liabilities to equity serves as an indicator of financial stability when funding costly cellular research.
Pesaing wigati
Utang jangka cendhak marang modal BIIB|NBIX - Kewajiban jangka cendhak marang modal|Regencell Bioscience - Rasio utang jangka cendhak marang ekuitas|Utang jangka cendhak marang modal axsome.com AXSM|ACAD - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal XENE (Xenon Pharmaceuticals Inc.)|Viking Pharma (VKTX) - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang modal Supernus Corp (SUPN)|CPRX (Catalyst Pharmaceuticals) - Utang jangka cendhak marang modal|Utang jangka cendhak marang modal denalitherapeutics.com|Utang jangka cendhak marang ekuitas Harmony Biosciences Holdings, Inc. (HRMY)|Utang jangka cendhak marang ekuitas BHVN (Biohaven Ltd)|Amylyx - Rasio utang jangka cendhak marang ekuitas|Rasio silihan jangka cendhak marang modal TRVI (Trevi Corp)|Praxis Precision Medicines - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal anavex.com|CeriBell (CBLL) - Utang jangka cendhak marang ekuitas|Prothena Biosciences - Rasio tanggungan utang jangka cendhak marang modal|ALEC (Alector Inc.) - Utang jangka cendhak marang modal|Annexon Biosciences Inc. (ANNX) - Koefisien utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas OMER (Omeros Corporation)|Rasio silihan jangka cendhak marang modal NGNE|AC Immune SA - Rasio utang jangka cendhak marang ekuitas|Voyager Therapeutics Inc (VYGR) - Kewajiban jangka cendhak marang modal|NMRA: Rasio utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal SCLX (Scilex Holding Company, Inc.)|TVGN (Tevogen Bio Holdings) - Rasio utang jangka cendhak marang ekuitas|ACOG: Rasio silihan jangka cendhak marang modal|CGTX (Cognition Therapeutics, Inc.) - Utang jangka cendhak marang modal|IKT: Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal SAVA|ASRT - Kewajiban jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Coya Therapeutics COYA|Rasio tanggungan utang jangka cendhak marang modal VTGN|Ovid Rx - Utang jangka cendhak marang modal|ABOS - Utang jangka cendhak marang modal|CervoMed Inc (CRVO) - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang ekuitas CLNN (Clene)|PEPG (PepGen Inc) - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal jupiterneurosciences.com JUNS|Rasio utang jangka cendhak marang ekuitas RLMD (Relmada Therapeutics, Inc.)|Utang jangka cendhak marang modal Annovis Bio Inc (ANVS)|Grace Therapeutics - Rasio utang jangka cendhak marang ekuitas|Rasio silihan jangka cendhak marang modal AIFF (Firefly Neuro)|ANEW Medical, Inc. - Utang jangka cendhak marang modal|Koefisien utang jangka cendhak marang modal NeuroSense Therapeutics NRSN|RVPH: Utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas MetaVia|Utang jangka cendhak marang ekuitas NeurAxis, Inc|Helius Medical Technologies Inc. (HSDT) - Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang modal PASG|Utang jangka cendhak marang modal bionomics.com.au (NEUP)|Minerva Neurosciences, Inc. - Rasio utang jangka cendhak marang ekuitas|Rasio silihan jangka cendhak marang modal ATHA (Athira Pharma Inc)|Addex Therapeutics, Ltd. - Utang jangka cendhak marang modal|Rasio tanggungan utang jangka cendhak marang modal ALZN (Alzamend Neuro, Inc.)|CYCN: Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Protagenic Therapeutics, Inc. (PTIX)|Utang jangka cendhak marang ekuitas Pasithea Therapeutics Corp|Rasio utang jangka cendhak marang modal CRGT (Cortigent Medical)|Utang jangka cendhak marang modal ATXI|BCLI - Kewajiban jangka cendhak marang modal|Cara Therapeutics, Inc. - Rasio utang jangka cendhak marang ekuitas|Utang jangka cendhak marang modal chromocell.com CHRO|ELYM - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal ITCI (Intra-Cellular Therapies)|Longboard Pharma (LBPH) - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang modal Marinus Pharma (MRNS)|NKGN (NKGen Biotech, Inc.) - Utang jangka cendhak marang modal|Utang jangka cendhak marang modal neurobopharma.com|Utang jangka cendhak marang ekuitas Sage Therapeutics (SAGE)|Utang jangka cendhak marang ekuitas SNPX (Synaptogenix Inc.)|Trevena, Inc - Rasio utang jangka cendhak marang ekuitas|Rasio silihan jangka cendhak marang modal VIGL (Vigil Neuroscience Inc.)|Anew Medical, Inc. - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal cerevel.com